Report overview
A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are either combined in ready form or mixed before administration. Safety, efficacy, and immunogenicity of a combined immunizing agent are high.
This report aims to provide a comprehensive presentation of the global market for Human Combination Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Combination Vaccines. This report contains market size and forecasts of Human Combination Vaccines in global, including the following market information:
Global Human Combination Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Human Combination Vaccines Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Human Combination Vaccines companies in 2022 (%)
The global Human Combination Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increase in pediatric population is one of the primary growth factors for this market. With the increase in pediatric population, the demand for combination vaccines for immunization is higher as newborn infants are more vulnerable to various infectious diseases due to weak immune systems. These vaccines help reduce the number of shots and healthcare center visits, which consequently save time and money. It has been observed that the occurrence of viral infections and diseases such as polio, tetanus, diphtheria, smallpox, chickenpox, and measles is high among children in developing nations.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Combination Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Combination Vaccines Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Human Combination Vaccines Market Segment Percentages, by Type, 2022 (%)
Human Combination Inactivated Vaccines
Human Combination Live Attenuated Vaccines
Global Human Combination Vaccines Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Human Combination Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Human Combination Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Human Combination Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Combination Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Combination Vaccines revenues share in global market, 2022 (%)
Key companies Human Combination Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Combination Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Sanofi
Daiichi Sankyo
Serum Institute of India
Takeda Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Combination Vaccines, market overview.
Chapter 2: Global Human Combination Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Human Combination Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Combination Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Combination Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
